These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 8996192)

  • 21. Effects of SP500263, a novel selective estrogen receptor modulator, on bone, uterus, and serum cholesterol in the ovariectomized rat.
    Sutherland MK; Brady H; Gayo-Fung LM; Leisten J; Lipps SG; McKie JA; O'Leary E; Patnaik N; Anderson DW; Bhagwat SS; Stein B
    Calcif Tissue Int; 2003 Jun; 72(6):710-6. PubMed ID: 14563000
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Raloxifene and vitamin K2 combine to improve the femoral neck strength of ovariectomized rats.
    Iwamoto J; Yeh JK; Schmidt A; Rowley E; Stanfield L; Takeda T; Sato M
    Calcif Tissue Int; 2005 Aug; 77(2):119-26. PubMed ID: 16059775
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Lasofoxifene enhances vaginal mucus formation without causing hypertrophy and increases estrogen receptor beta and androgen receptor in rats.
    Wang XN; Simmons HA; Salatto CT; Cosgrove PG; Thompson DD
    Menopause; 2006; 13(4):609-20. PubMed ID: 16837883
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A comparison of the effects of raloxifene and conjugated equine estrogen on bone and lipids in healthy postmenopausal women.
    Reid IR; Eastell R; Fogelman I; Adachi JD; Rosen A; Netelenbos C; Watts NB; Seeman E; Ciaccia AV; Draper MW
    Arch Intern Med; 2004 Apr; 164(8):871-9. PubMed ID: 15111373
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Dosing time-dependent effect of raloxifene on plasma fibrinogen concentration in ovariectomized rats.
    Tsuruoka S; Hasegawa G; Kaneda T; Maeda A; Fujimura A
    Chronobiol Int; 2008 Sep; 25(5):808-18. PubMed ID: 18780206
    [TBL] [Abstract][Full Text] [Related]  

  • 26. NTP Toxicology and Carcinogenesis Studies of Promethazine Hydrochloride (CAS No. 58-33-3) in F344/N Rats and B6C3F1 Mice (Gavage Studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 1993 Dec; 425():1-272. PubMed ID: 12616286
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Raloxifene blocks estradiol induction of the serotonin transporter and 5-hydroxytryptamine2A receptor in female rat brain.
    Sumner BE; Grant KE; Rosie R; Hegele-Hartung Ch; Fritzemeier KH; Fink G
    Neurosci Lett; 2007 Apr; 417(1):95-9. PubMed ID: 17398000
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Differential effects of raloxifene and continuous combined hormone replacement therapy on biochemical markers of cardiovascular risk: results from the Euralox 1 study.
    Nickelsen T; Creatsas G; Rechberger T; Depypere H; Erenus M; Quail D; Arndt T; Bonnar J;
    Climacteric; 2001 Dec; 4(4):320-31. PubMed ID: 11770189
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effects of raloxifene on lipid and lipoprotein levels in postmenopausal osteoporotic women with and without hypertriglyceridemia.
    Dayspring T; Qu Y; Keech C
    Metabolism; 2006 Jul; 55(7):972-9. PubMed ID: 16784972
    [TBL] [Abstract][Full Text] [Related]  

  • 30. NTP Toxicology and Carcinogenesis Studies of Pentachloroanisole (CAS No. 1825-21-4) in F344 Rats and B6C3F1 Mice (Feed Studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 1993 Apr; 414():1-284. PubMed ID: 12616284
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Influence of oestrogenic compounds on monoamine transporters in rat striatum.
    Le Saux M; Di Paolo T
    J Neuroendocrinol; 2006 Jan; 18(1):25-32. PubMed ID: 16451217
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The selective estrogen receptor modulator, raloxifene: an overview of nonclinical pharmacology and reproductive and developmental testing.
    Buelke-Sam J; Bryant HU; Francis PC
    Reprod Toxicol; 1998; 12(3):217-21. PubMed ID: 9628546
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Raloxifene inhibits bone turnover and prevents further cancellous bone loss in adult ovariectomized rats with established osteopenia.
    Evans GL; Bryant HU; Magee DE; Turner RT
    Endocrinology; 1996 Oct; 137(10):4139-44. PubMed ID: 8828469
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Raloxifene, tamoxifen, nafoxidine, or estrogen effects on reproductive and nonreproductive tissues in ovariectomized rats.
    Sato M; Rippy MK; Bryant HU
    FASEB J; 1996 Jun; 10(8):905-12. PubMed ID: 8666168
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Hypocholesterolemic action of the selective estrogen receptor modulator acolbifene in intact and ovariectomized rats with diet-induced hypercholesterolemia.
    Lemieux C; Gélinas Y; Lalonde J; Labrie F; Richard D; Deshaies Y
    Metabolism; 2006 May; 55(5):605-13. PubMed ID: 16631436
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Antagonism of estrogen action with a new benzothiophene derived antiestrogen.
    Black LJ; Jones CD; Falcone JF
    Life Sci; 1983 Feb; 32(9):1031-6. PubMed ID: 6827921
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Raloxifene inhibits aortic accumulation of cholesterol in ovariectomized, cholesterol-fed rabbits.
    Bjarnason NH; Haarbo J; Byrjalsen I; Kauffman RF; Christiansen C
    Circulation; 1997 Sep; 96(6):1964-9. PubMed ID: 9323087
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The selective estrogen receptor modulator, raloxifene: segment II studies in rats and rabbits.
    Byrd RA; Francis PC
    Reprod Toxicol; 1998; 12(3):261-70. PubMed ID: 9628550
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A new selective estrogen receptor modulator with potent uterine antagonist activity, agonist activity in bone, and minimal ovarian stimulation.
    Geiser AG; Hummel CW; Draper MW; Henck JW; Cohen IR; Rudmann DG; Donnelly KB; Adrian MD; Shepherd TA; Wallace OB; McCann DJ; Oldham SW; Bryant HU; Sato M; Dodge JA
    Endocrinology; 2005 Oct; 146(10):4524-35. PubMed ID: 16002528
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Inhibition of LDL oxidation and myeloperoxidase dependent tyrosyl radical formation by the selective estrogen receptor modulator raloxifene (LY139481 HCL).
    Zuckerman SH; Bryan N
    Atherosclerosis; 1996 Sep; 126(1):65-75. PubMed ID: 8879435
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.